{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:10:31Z","timestamp":1788923431810,"version":"build-2803163510"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11916-024-01310-x","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T04:59:45Z","timestamp":1735966785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy, Indications, and Safety of Intrathecal Baclofen Pump: A Narrative Review"],"prefix":"10.1007","volume":"29","author":[{"given":"Alan D.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Yun","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan H.","family":"Roque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlee R.","family":"Mott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex M.","family":"Wandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda T.","family":"Munir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Siddaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin Nicole","family":"Bembenick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"issue":"9","key":"1310_CR1","doi-asserted-by":"publisher","first-page":"10266","DOI":"10.3390\/molecules180910266","volume":"18","author":"M Attia","year":"2013","unstructured":"Attia M, Herdeis C, Br\u00e4uner-Osborne H. GABAB-Agonistic Activity of Certain Baclofen Homologues. Molecules. 2013;18(9):10266\u201384.","journal-title":"Molecules"},{"issue":"11","key":"1310_CR2","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/S0028-3908(99)00126-4","volume":"38","author":"J Yamada","year":"1999","unstructured":"Yamada J. GABAB receptor-mediated presynaptic inhibition of glutamatergic and GABAergic transmission in the basolateral amygdala. Neuropharmacology. 1999;38(11):1743\u201353.","journal-title":"Neuropharmacology"},{"key":"1310_CR3","unstructured":"LIORESAL \u00aeINTRATHECAL(baclofen injection). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/020075s021lbl.pdf."},{"key":"1310_CR4","unstructured":"OZOBAX (baclofen) oral solution. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/208193s000lbl.pdf."},{"issue":"5","key":"1310_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.12968\/bjon.1997.6.5.253","volume":"6","author":"B Porter","year":"1997","unstructured":"Porter B. A review of intrathecal baclofen in the management of spasticity. Br J Nurs. 1997;6(5):253\u201362.","journal-title":"Br J Nurs."},{"issue":"9","key":"1310_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/ncpneuro0868","volume":"4","author":"BS Russman","year":"2008","unstructured":"Russman BS. Continuous intrathecal baclofen infusion for intractable spastic cerebral palsy\u2014is it worth it? Nat Clin Pract Neurol. 2008;4(9):476\u20137.","journal-title":"Nat Clin Pract Neurol"},{"issue":"1","key":"1310_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.apmr.2022.05.011","volume":"104","author":"N Dietz","year":"2023","unstructured":"Dietz N, et al. Intrathecal and Oral Baclofen Use in Adults With Spinal Cord Injury: A Systematic Review of Efficacy in Spasticity Reduction, Functional Changes, Dosing, and Adverse Events. Arch Phys Med Rehabil. 2023;104(1):119\u201331.","journal-title":"Arch Phys Med Rehabil."},{"issue":"3","key":"1310_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2340\/16501977-2211","volume":"49","author":"P Ertzgaard","year":"2017","unstructured":"Ertzgaard P, Campo C, Calabrese A. Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen. J Rehabil Med. 2017;49(3):193\u2013203.","journal-title":"J Rehabil Med"},{"issue":"10","key":"1310_CR9","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1017\/S0012162201001190","volume":"43","author":"AL Albright","year":"2001","unstructured":"Albright AL, et al. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol. 2001;43(10):652.","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"1310_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2176\/nmc.52.463","volume":"52","author":"T Uchiyama","year":"2012","unstructured":"Uchiyama T, et al. Neuromodulation Using Intrathecal Baclofen Therapy for Spasticity and Dystonia. Neurol Med Chir (Tokyo). 2012;52(7):463\u20139.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"34","key":"1310_CR11","doi-asserted-by":"publisher","first-page":"e7472","DOI":"10.1097\/MD.0000000000007472","volume":"96","author":"YK Yoon","year":"2017","unstructured":"Yoon YK, et al. Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury. Medicine (Baltimore). 2017;96(34):e7472.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1310_CR12","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1007\/s10143-021-01550-0","volume":"44","author":"A Kudva","year":"2021","unstructured":"Kudva A, et al. Intrathecal baclofen, selective dorsal rhizotomy, and extracorporeal shockwave therapy for the treatment of spasticity in cerebral palsy: a systematic review. Neurosurg Rev. 2021;44(6):3209\u201328.","journal-title":"Neurosurg Rev"},{"issue":"7","key":"1310_CR13","first-page":"1","volume":"5","author":"Medical Advisory Secretariat","year":"2005","unstructured":"Medical Advisory Secretariat. Intrathecal baclofen pump for spasticity: an evidence-based analysis. Ont Health Technol Assess Ser. 2005;5(7):1\u201393.","journal-title":"Ont Health Technol Assess Ser"},{"issue":"11","key":"1310_CR14","first-page":"799","volume":"27","author":"A Dario","year":"2004","unstructured":"Dario A, Tomei G. A Benefit-Risk Assessment of Baclofen in Severe Spinal Spasticity: Drug Saf. 2004;27(11):799\u2013818.","journal-title":"A Benefit-Risk Assessment of Baclofen in Severe Spinal Spasticity: Drug Saf"},{"key":"1310_CR15","unstructured":"Harb A, Kishner S. Modified Ashworth Scale. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024."},{"issue":"6","key":"1310_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/ner.12447","volume":"19","author":"M Saulino","year":"2016","unstructured":"Saulino M, et al. Best Practices for Intrathecal Baclofen Therapy: Patient Selection. Neuromodulation Technol Neural Interface. 2016;19(6):607\u201315.","journal-title":"Neuromodulation Technol Neural Interface"},{"key":"1310_CR17","doi-asserted-by":"publisher","first-page":"205031212110221","DOI":"10.1177\/20503121211022197","volume":"9","author":"JW Romito","year":"2021","unstructured":"Romito JW, et al. Baclofen therapeutics, toxicity, and withdrawal: A narrative review. SAGE Open Med. 2021;9:205031212110221.","journal-title":"SAGE Open Med"},{"issue":"6","key":"1310_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/ner.12388","volume":"19","author":"AL Boster","year":"2016","unstructured":"Boster AL, et al. Best Practices for Intrathecal Baclofen Therapy: Dosing and Long-Term Management. Neuromodulation Technol Neural Interface. 2016;19(6):623\u201331.","journal-title":"Neuromodulation Technol Neural Interface"},{"key":"1310_CR19","doi-asserted-by":"publisher","unstructured":"G\u00fcnd\u00fcz HB. Results of Intrathecal Baclofen Treatment in Sixteen Spasticity Patients According to Four Different Measurement Scales: A Retrospective Analysis. Cureus. 2022;14(7). https:\/\/doi.org\/10.7759\/cureus.26980.","DOI":"10.7759\/cureus.26980"},{"issue":"12","key":"1310_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11916-021-00994-9","volume":"25","author":"A Marathe","year":"2021","unstructured":"Marathe A, et al. Intrathecal Baclofen Monotherapy and Polyanalgesia for Treating Chronic Pain in Patients with Severe Spasticity. Curr Pain Headache Rep. 2021;25(12):79.","journal-title":"Curr Pain Headache Rep"},{"issue":"4","key":"1310_CR21","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3171\/2017.5.JNS162925","volume":"129","author":"BS Lee","year":"2018","unstructured":"Lee BS, et al. Early outcomes after intrathecal baclofen therapy in ambulatory patients with multiple sclerosis. J Neurosurg. 2018;129(4):1056\u201362.","journal-title":"J Neurosurg"},{"issue":"6","key":"1310_CR22","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ejpn.2013.06.003","volume":"17","author":"GF Vles","year":"2013","unstructured":"Vles GF, et al. Long-term follow-up on continuous intrathecal Baclofen therapy in non-ambulant children with intractable spastic Cerebral Palsy. Eur J Paediatr Neurol. 2013;17(6):639\u201344.","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"1310_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5535\/arm.23003","volume":"47","author":"S-R Cho","year":"2023","unstructured":"Cho S-R. Intrathecal Baclofen Therapy: Pros and Cons. Ann Rehabil Med. 2023;47(1):1\u20133.","journal-title":"Ann Rehabil Med"},{"issue":"4","key":"1310_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.5606\/tftrd.2022.9596","volume":"68","author":"E G\u00fcnt\u00fcrk","year":"2022","unstructured":"G\u00fcnt\u00fcrk E. The effect of oral baclofen and botulinum toxin treatments in hemiplegic spasticity on the nociceptive flexor reflex: A randomized clinical trial. Turk J Phys Med Rehabil. 2022;68(4):524\u201331.","journal-title":"Turk J Phys Med Rehabil"},{"key":"1310_CR25","doi-asserted-by":"publisher","first-page":"205031212110221","DOI":"10.1177\/20503121211022197","volume":"9","author":"JW Romito","year":"2021","unstructured":"Romito JW, et al. Baclofen therapeutics, toxicity, and withdrawal: A narrative review. SAGE Open Med. 2021;9:20503121211022196.","journal-title":"SAGE Open Med"},{"issue":"1\u20132","key":"1310_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1615\/CritRevPhysRehabilMed.2013007945","volume":"25","author":"E Chang","year":"2013","unstructured":"Chang E, et al. A Review of Spasticity Treatments: Pharmacological and Interventional Approaches. Crit Rev Phys Rehabil Med. 2013;25(1\u20132):11\u201322.","journal-title":"Crit Rev Phys Rehabil Med"},{"issue":"2","key":"1310_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1525-1403.2000.00075.x","volume":"3","author":"AM Avellino","year":"2000","unstructured":"Avellino AM, Loeser JD. Intrathecal Baclofen for the Treatment of Intractable Spasticity of Spine or Brain Etiology. Neuromodulation Technol Neural Interface. 2000;3(2):75\u201381.","journal-title":"Neuromodulation Technol Neural Interface"},{"key":"1310_CR28","unstructured":"Spasticity Management After Stroke - ClinicalKey [Internet]. https:\/\/www.clinicalkey.com\/#!\/content\/playContent\/1-s2.0-S1047965115000601?scrollTo=%23hl0000480. Accessed April 21, 2024."},{"key":"1310_CR29","doi-asserted-by":"publisher","first-page":"102831","DOI":"10.1016\/j.msard.2021.102831","volume":"50","author":"R Farrell","year":"2021","unstructured":"Farrell R, et al. Evaluation of the cognitive benefits of intrathecal baclofen pump implantation in people with intractable multiple sclerosis related spasticity. Mult Scler Relat Disord. 2021;50:102831.","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"1310_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1191\/0269215506cr940oa","volume":"20","author":"SM Leary","year":"2006","unstructured":"Leary SM, et al. Intrathecal baclofen therapy improves functional intelligibility of speech in cerebral palsy. Clin Rehabil. 2006;20(3):228\u201331.","journal-title":"Clin Rehabil"},{"issue":"1","key":"1310_CR31","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1542\/peds.111.1.e89","volume":"111","author":"TD Sanger","year":"2003","unstructured":"Sanger TD, et al. Classification and Definition of Disorders Causing Hypertonia in Childhood. Pediatrics. 2003;111(1):e89\u201397.","journal-title":"Pediatrics"},{"issue":"2","key":"1310_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3171\/2023.11.PEDS23473","volume":"33","author":"S Abdelmageed","year":"2023","unstructured":"Abdelmageed S, et al. Safety and efficacy of intrathecal baclofen trials for the treatment of hypertonia: a retrospective cohort study. J Neurosurg Pediatr. 2023;33(2):179\u201384.","journal-title":"J Neurosurg Pediatr"},{"issue":"10","key":"1310_CR33","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41393-018-0153-4","volume":"56","author":"O Kawano","year":"2018","unstructured":"Kawano O, et al. The dosage and administration of long-term intrathecal baclofen therapy for severe spasticity of spinal origin. Spinal Cord. 2018;56(10):996\u20139.","journal-title":"Spinal Cord"},{"issue":"12","key":"1310_CR34","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1177\/0269215513488607","volume":"27","author":"N Draulans","year":"2013","unstructured":"Draulans N, et al. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution. Clin Rehabil. 2013;27(12):1137\u201343.","journal-title":"Clin Rehabil"},{"issue":"12","key":"1310_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2176\/jns-nmc.2022-0359","volume":"63","author":"Y Kimoto","year":"2023","unstructured":"Kimoto Y, et al. Characteristics of Changes in Intrathecal Baclofen Dosage over Time due to Causative Disease. Neurol Med Chir (Tokyo). 2023;63(12):535\u201341.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"7","key":"1310_CR36","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/ner.13340","volume":"24","author":"I \u0160t\u011btk\u00e1\u0159ov\u00e1","year":"2021","unstructured":"\u0160t\u011btk\u00e1\u0159ov\u00e1 I, Kr\u00e1msk\u00e1 L, Keller J. Improvement of Memory Functions in Chronic Spinal Cord Injury After Long-Term Intrathecal Baclofen Delivery for Spasticity Relief. Neuromodulation Technol Neural Interface. 2021;24(7):1199\u2013203.","journal-title":"Neuromodulation Technol Neural Interface"},{"issue":"8","key":"1310_CR37","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00381-021-05154-3","volume":"37","author":"J Gburek-Augustat","year":"2021","unstructured":"Gburek-Augustat J, et al. Unusual mechanical failures of intrathecal baclofen pump systems: symptoms, signs, and trouble shooting. Childs Nerv Syst. 2021;37(8):2597\u2013604.","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"1310_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/088307389601100202","volume":"11","author":"AL Albright","year":"1996","unstructured":"Albright AL. Baclofen in the treatment of cerebral palsy. J Child Neurol. 1996;11(2):77\u201383.","journal-title":"J Child Neurol"},{"issue":"10","key":"1310_CR39","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41393-018-0153-4","volume":"56","author":"O Kawano","year":"2018","unstructured":"Kawano O, et al. The dosage and administration of long-term intrathecal baclofen therapy for severe spasticity of spinal origin. Spinal Cord. 2018;56(10):996\u20139.","journal-title":"Spinal Cord"},{"key":"1310_CR40","unstructured":"Guzman E, et al. Position-Dependent Intrathecal Baclofen System Catheter Failure Resulting in Debilitating Spasticity: A Case Report. Cureus;16(2):e53425."},{"issue":"6","key":"1310_CR41","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/00002060-200011000-00010","volume":"79","author":"L Stempien","year":"2000","unstructured":"Stempien L, Tsai T. Intrathecal Baclofen Pump Use for Spasticity: A Clinical Survey. Am J Phys Med Rehabil. 2000;79(6):536.","journal-title":"Am J Phys Med Rehabil"},{"issue":"2","key":"1310_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bjae.2019.11.002","volume":"20","author":"EM Delhaas","year":"2020","unstructured":"Delhaas EM, Huygen FJPM. Complications associated with intrathecal drug delivery systems. BJA Educ. 2020;20(2):51\u20137.","journal-title":"BJA Educ"},{"issue":"1","key":"1310_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.apmr.2022.05.011","volume":"104","author":"N Dietz","year":"2023","unstructured":"Dietz N, et al. Intrathecal and Oral Baclofen Use in Adults With Spinal Cord Injury: A Systematic Review of Efficacy in Spasticity Reduction, Functional Changes, Dosing, and Adverse Events. Arch Phys Med Rehabil. 2023;104(1):119\u201331.","journal-title":"Arch Phys Med Rehabil"},{"key":"1310_CR44","doi-asserted-by":"publisher","first-page":"205031212110221","DOI":"10.1177\/20503121211022197","volume":"9","author":"JW Romito","year":"2021","unstructured":"Romito JW, et al. Baclofen therapeutics, toxicity, and withdrawal: A narrative review. SAGE Open Med. 2021;9:20503121211022196.","journal-title":"SAGE Open Med"},{"issue":"05","key":"1310_CR45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1055\/s-0034-1387818","volume":"45","author":"S Berweck","year":"2014","unstructured":"Berweck S, et al. Use of Intrathecal Baclofen in Children and Adolescents: Interdisciplinary Consensus Table 2013. Neuropediatrics. 2014;45(05):294\u2013308.","journal-title":"Neuropediatrics"},{"key":"1310_CR46","unstructured":"Ghanavatian S, Derian A. Baclofen. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024."},{"issue":"6","key":"1310_CR47","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/ner.12447","volume":"19","author":"M Saulino","year":"2016","unstructured":"Saulino M, et al. Best Practices for Intrathecal Baclofen Therapy: Patient Selection. Neuromodulation Technol Neural Interface. 2016;19(6):607\u201315.","journal-title":"Neuromodulation Technol Neural Interface"},{"issue":"6","key":"1310_CR48","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.pmrj.2013.12.005","volume":"6","author":"SN Mathur","year":"2014","unstructured":"Mathur SN, et al. Long-term Intrathecal Baclofen: Outcomes After More than 10 Years of Treatment. PM&R. 2014;6(6):506-513.e1.","journal-title":"PM&R"},{"key":"1310_CR49","doi-asserted-by":"publisher","unstructured":"Hashemi M, et al. Surgical Approaches to Upper Limb Spasticity in Adult Patients: A Literature Review. Front Rehabil Sci. 2021;2. https:\/\/doi.org\/10.3389\/fresc.2021.709969.","DOI":"10.3389\/fresc.2021.709969"},{"issue":"6","key":"1310_CR50","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.pmrj.2015.10.005","volume":"8","author":"ZL McCormick","year":"2016","unstructured":"McCormick ZL, et al. Intrathecal Versus Oral Baclofen: A Matched Cohort Study of Spasticity, Pain, Sleep, Fatigue, and Quality of Life. PM&R. 2016;8(6):553\u201362.","journal-title":"PM&R"},{"issue":"21","key":"1310_CR51","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.3390\/healthcare11212820","volume":"11","author":"AZ Qureshi","year":"2023","unstructured":"Qureshi AZ, et al. Complications of Intrathecal Baclofen Pump Therapy: An Institutional Experience from Saudi Arabia. Healthcare. 2023;11(21):2820.","journal-title":"Healthcare"},{"key":"1310_CR52","doi-asserted-by":"crossref","unstructured":"Beard S, Hunn A, Wight J. Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technol Assess Winch Engl. 2003;7(40):iii, ix\u2013x, 1\u2013111.","DOI":"10.3310\/hta7400"},{"key":"1310_CR53","first-page":"15","volume":"1","author":"J Ashton","year":"2011","unstructured":"Ashton J. Emerging treatment options for spasticity in multiple sclerosis – clinical utility of cannabinoids. Degener Neurol Neuromuscul Dis. 2011;1:15\u201323.","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"3","key":"1310_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2217\/nmt-2022-0002","volume":"12","author":"A Chan","year":"2022","unstructured":"Chan A, Silv\u00e1n CV. Evidence-based Management of Multiple Sclerosis Spasticity With Nabiximols Oromucosal Spray in Clinical Practice: A 10-year Recap. Neurodegener Dis Manag. 2022;12(3):141\u201354.","journal-title":"Neurodegener Dis Manag"},{"key":"1310_CR55","doi-asserted-by":"crossref","unstructured":"Solmi M, et al. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies. BMJ. 2023;e072348.","DOI":"10.1136\/bmj-2022-072348"},{"issue":"10","key":"1310_CR56","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.rehab.2009.09.005","volume":"52","author":"AP Yelnik","year":"2009","unstructured":"Yelnik AP, et al. Drug treatments for spasticity. Ann Phys Rehabil Med. 2009;52(10):746\u201356.","journal-title":"Ann Phys Rehabil Med"},{"issue":"11","key":"1310_CR57","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/toxins14110772","volume":"14","author":"CS Kaya Keles","year":"2022","unstructured":"Kaya Keles CS, Ates F. Botulinum Toxin Intervention in Cerebral Palsy-Induced Spasticity Management: Projected and Contradictory Effects on Skeletal Muscles. Toxins. 2022;14(11):772.","journal-title":"Toxins"},{"issue":"2","key":"1310_CR58","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1017\/cjn.2015.314","volume":"43","author":"CP Phadke","year":"2016","unstructured":"Phadke CP, et al. Adverse Clinical Effects of Botulinum Toxin Intramuscular Injections for Spasticity. Can J Neurol Sci J Can Sci Neurol. 2016;43(2):298\u2013310.","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"issue":"5","key":"1310_CR59","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/dmcn.14733","volume":"63","author":"MR Delgado","year":"2021","unstructured":"Delgado MR, et al. Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study. Dev Med Child Neurol. 2021;63(5):592\u2013600.","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"1310_CR60","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.hansur.2022.04.006","volume":"41","author":"I Jarratt Barnham","year":"2022","unstructured":"Jarratt Barnham I, et al. Surgical interventions in adult upper limb spasticity management: a systematic review. Hand Surg Rehabil. 2022;41(4):426\u201334.","journal-title":"Hand Surg Rehabil"},{"issue":"6","key":"1310_CR61","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/WCO.0000000000001114","volume":"35","author":"S Tamburin","year":"2022","unstructured":"Tamburin S, et al. Spasticity following brain and spinal cord injury: assessment and treatment. Curr Opin Neurol. 2022;35(6):728.","journal-title":"Curr Opin Neurol"},{"key":"1310_CR62","unstructured":"Health C for D and R. Prometra Programmable Infusion Pump System \u2013 P080012\/S068. FDA. [published online ahead of print: March 28, 2022]. https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/prometra-programmable-infusion-pump-system-p080012s068. Accessed May 4, 2024."},{"issue":"6","key":"1310_CR63","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/PHM.0000000000002397","volume":"103","author":"J Weppner","year":"2024","unstructured":"Weppner J, et al. Traditional Lecture Versus Procedural Video Randomized Trial: Comparative Analysis of Instructional Methods for Teaching Baclofen Pump Management. Am J Phys Med Rehabil. 2024;103(6):510\u20137.","journal-title":"Am J Phys Med Rehabil"},{"issue":"11","key":"1310_CR64","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/pmrj.12982","volume":"15","author":"SN Stone","year":"2023","unstructured":"Stone SN, Wei D, Reger C. Ultrasound guidance versus landmark guidance for intrathecal baclofen pump refill: A randomized pilot study. PM&R. 2023;15(11):1425\u201330.","journal-title":"PM&R"},{"key":"1310_CR65","unstructured":"Konrad P. Intrathecal (IT) Baclofen Drug Distribution Pilot Study. clinicaltrials.gov; 2022."},{"key":"1310_CR66","doi-asserted-by":"crossref","unstructured":"Creamer MJ, et al. Poster 462: Efficacy of Intrathecal Baclofen Therapy Compared to Conventional Oral Treatment in Post-Stroke Spasticity: An International Multicenter Randomized Controlled Trial (SISTERS). PM&R. 2017;9(9S1):S279\u2013S280.","DOI":"10.1016\/j.pmrj.2017.08.409"},{"key":"1310_CR67","unstructured":"MedtronicNeuro. A Randomized, Controlled, Open-label, Parallel-group, Multi-center Study to Compare the Effect of Intrathecal Baclofen Therapy Versus Best Medical Treatment on Severe Spasticity in Post-stroke Patients After 6 Months Active Treatment. clinicaltrials.gov; 2018."},{"key":"1310_CR68","unstructured":"University Hospital, Ghent. Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity. clinicaltrials.gov; 2007."},{"key":"1310_CR69","unstructured":"Vanderbilt University. Vanderbilt University Spasticity Management Program Evaluation Plan. clinicaltrials.gov; 2007."},{"key":"1310_CR70","unstructured":"Maastricht University. Intrathecal Baclofen. Evaluation of a Therapy for Refractory Spasticity in Children With Cerebral Palsy. clinicaltrials.gov; 2007."},{"key":"1310_CR71","unstructured":"MedtronicNeuro. Feasibility of Measuring Cerebrospinal Fluid (CSF) Signatures in Subjects With Intrathecal Catheter-Related Problems. clinicaltrials.gov; 2017."},{"key":"1310_CR72","unstructured":"Piramal Critical Care, Ltd. Study to Assess the Safety of 3 mg\/mL Gablofen\u00ae (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed\u00ae II Programmable Infusion System. clinicaltrials.gov; 2019."},{"key":"1310_CR73","doi-asserted-by":"crossref","unstructured":"Kumru H. Effect of Intrathecal Baclofen (ITB) Bolus on Neuropathic Pain (NP) in Spinal Cord Injury (SCI) Patients. Preliminary Study.. clinicaltrials.gov; 2019.","DOI":"10.1016\/j.brainresbull.2018.05.013"},{"key":"1310_CR74","unstructured":"Solent NHS Trust. A Feasibility Study Monitoring the Respiratory Status of Participants Receiving or Scheduled to Receive Intrathecal Baclofen (ITB). clinicaltrials.gov; 2017."},{"key":"1310_CR75","unstructured":"Study Details | Safety Study of 3 mg\/mL Baclofen Injection (Intrathecal) Using A Programmable Pump | ClinicalTrials.gov [Internet]. https:\/\/clinicaltrials.gov\/study\/NCT01520545. Accessed July 15, 2024."},{"issue":"6","key":"1310_CR76","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/jnnp-2017-317021","volume":"89","author":"M Creamer","year":"2018","unstructured":"Creamer M, et al. Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS). J Neurol Neurosurg Psychiatry. 2018;89(6):642\u201350.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1310_CR77","unstructured":"Intrathecal (IT) Baclofen Drug Distribution [Internet]. ctv.veeva.com. https:\/\/ctv.veeva.com\/study\/intrathecal-it-baclofen-drug-distribution. Accessed July 15, 2024."}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-024-01310-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-024-01310-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-024-01310-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:02:54Z","timestamp":1771275774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-024-01310-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1310"],"URL":"https:\/\/doi.org\/10.1007\/s11916-024-01310-x","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"20 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"ADK is the section editor for CPHRs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"9"}}